Primary Adenocarcinoma of the Minor Duodenal Papilla

por Wakatsuki, Takeru, Irisawa, Atsushi, Takagi, Tadayuki, Koyama, Yoshihisa, Hoshi, Sayuri, Takenoshita, Seiichi, Abe, Masafumi, Ohira, Hiromasa
Publicado 2008

Efficacy of aluminum chloride in severe regorafenib-associated hand-foot skin reactions: a single-arm trial

por Nishizawa, Aya, Shinozaki, Eiji, Wakatsuki, Takeru, Satoh, Takahiro, Yamazaki, Naoya, Oyamada, Shunsuke, Ariyoshi, Keisuke, Kihara, Kota, Tsuboi, Masahiro, Yamaguchi, Kensei
Publicado 2023

Two Cases of Long-Term Survival of Advanced Colorectal Cancer with Synchronous Lung Metastases Treated with mFOLFOX6/XELOX + Bevacizumab

por Ushida, Yuta, Shinozaki, Eiji, Chin, Keisho, Suenaga, Mitsukuni, Takahari, Daisuke, Ozaka, Masato, Ogura, Mariko, Ichimura, Takashi, Wakatsuki, Takeru, Yamaguchi, Kensei
Publicado 2018

Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer

por Osumi, Hiroki, Shinozaki, Eiji, Takeda, Yoshinori, Wakatsuki, Takeru, Ichimura, Takashi, Saiura, Akio, Yamaguchi, Kensei, Takahashi, Shunji, Noda, Tetsuo, Zembutsu, Hitoshi
Publicado 2018

Association Between Regorafenib Dose and Efficacy Against Metastatic Colorectal Cancer in a Real-World Setting

por Hatori, Masahiro, Kawakami, Kazuyoshi, Wakatsuki, Takeru, Shinozaki, Eiji, Kobayashi, Kazuo, Aoyama, Takeshi, Nakano, Yasuhiro, Suzuki, Kenichi, Yamaguchi, Kensei, Hama, Toshihiro
Publicado 2021

Neutralization of the induced VEGF-A potentiates the therapeutic effect of an anti-VEGFR2 antibody on gastric cancer in vivo

por Mashima, Tetsuo, Wakatsuki, Takeru, Kawata, Naomi, Jang, Myung-Kyu, Nagamori, Akiko, Yoshida, Haruka, Nakamura, Kenichi, Migita, Toshiro, Seimiya, Hiroyuki, Yamaguchi, Kensei
Publicado 2021

Early hypertension and neutropenia are predictors of treatment efficacy in metastatic colorectal cancer patients administered FOLFIRI and vascular endothelial growth factor inhibit...

por Osumi, Hiroki, Shinozaki, Eiji, Ooki, Akira, Wakatsuki, Takeru, Kamiimabeppu, Daisaku, Sato, Taro, Nakayama, Izuma, Ogura, Mariko, Takahari, Daisuke, Chin, Keisho, Yamaguchi, Kensei
Publicado 2020

Correlation between circulating tumor DNA and carcinoembryonic antigen levels in patients with metastatic colorectal cancer

por Osumi, Hiroki, Shinozaki, Eiji, Ooki, Akira, Shimozaki, Keitaro, Kamiimabeppu, Daisaku, Nakayama, Izuma, Wakatsuki, Takeru, Ogura, Mariko, Takahari, Daisuke, Chin, Keisho, Yamaguchi, Kensei
Publicado 2021

Safety evaluation of fixed‐dose nivolumab in patients with gastric cancer

por Iikura, Yusuke, Aoyama, Takeshi, Hiraide, Makoto, Wakatsuki, Takeru, Nakayama, Izuma, Ogura, Mariko, Ooki, Akira, Takahari, Daisuke, Chin, Keisho, Yamaguchi, Kensei, Hama, Toshihiro
Publicado 2022

Clinical Progress in Inoperable or Recurrent Advanced Gastric Cancer Treatment from 1004 Single Institute Experiences Between 2007 and 2018

por Nakayama, Izuma, Takahari, Daisuke, Shimozaki, Keitaro, Chin, Keisho, Wakatsuki, Takeru, Ogura, Mariko, Ooki, Akira, Kamiimabeppu, Daisaku, Osumi, Hiroki, Shinozaki, Eiji, Yamaguchi, Kensei
Publicado 2022

Single-organ pulmonary metastasis is a favorable prognostic factor in metastatic colorectal cancer patients treated with FOLFIRI and vascular endothelial growth factor inhibitors

por Fukuda, Koshiro, Osumi, Hiroki, Yoshino, Koichiro, Nakayama, Izuma, Fukuoka, Shota, Ogura, Mariko, Wakatsuki, Takeru, Ooki, Akira, Takahari, Daisuke, Chin, Keisho, Yamaguchi, Kensei, Shinozaki, Eiji
Publicado 2023

Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer

por Suenaga, Mitsukuni, Mashima, Tetsuo, Kawata, Naomi, Wakatsuki, Takeru, Horiike, Yuki, Matsusaka, Satoshi, Dan, Shingo, Shinozaki, Eiji, Seimiya, Hiroyuki, Mizunuma, Nobuyuki, Yamaguchi, Kensei, Yamaguchi, Toshiharu
Publicado 2016

Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients

por Nakayama, Izuma, Shinozaki, Eiji, Matsushima, Tomohiro, Wakatsuki, Takeru, Ogura, Mariko, Ichimura, Takashi, Ozaka, Masato, Takahari, Daisuke, Suenaga, Mitsukuni, Chin, Keisho, Mizunuma, Nobuyuki, Yamaguchi, Kensei
Publicado 2017

Treatment features of systemic chemotherapy in young adults with unresectable advanced or recurrent gastric cancer

por Nakayama, Izuma, Chin, Keisho, Takahari, Daisuke, Ogura, Mariko, Ichimura, Takashi, Wakatsuki, Takeru, Osumi, Hiroki, Ota, Yumiko, Suzuki, Takeshi, Suenaga, Mitsukuni, Shinozaki, Eiji, Yamaguchi, Kensei
Publicado 2018

Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer

por Kawakami, Kazuyoshi, Wakatsuki, Takeru, Soejima, Azusa, Kobayashi, Kazuo, Yokokawa, Takashi, Aoyama, Takeshi, Suzuki, Kenichi, Suenaga, Mitsukuni, Yamaguchi, Kensei, Inoue, Ayaka, Machida, Yoshiaki, Hama, Toshihiro
Publicado 2019

Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancer

por Kawai, Sadayuki, Fukuda, Naoki, Yamamoto, Shun, Mitani, Seiichiro, Omae, Katsuhiro, Wakatsuki, Takeru, Kato, Ken, Kadowaki, Shigenori, Takahari, Daisuke, Boku, Narikazu, Muro, Kei, Machida, Nozomu
Publicado 2020

Effect of neutropenia on survival outcomes of patients with metastatic colorectal cancer receiving trifluridine/tipiracil plus bevacizumab

por Kamiimabeppu, Daisaku, Osumi, Hiroki, Shinozaki, Eiji, Ooki, Akira, Wakatsuki, Takeru, Yoshino, Koichiro, Sato, Taro, Nakayama, Izuma, Ogura, Mariko, Takahari, Daisuke, Chin, Keisho, Yamaguchi, Kensei
Publicado 2021

Early hypertension is associated with better clinical outcomes in gastric cancer patients treated with ramucirumab plus paclitaxel

por Fukuda, Naoki, Takahari, Daisuke, Wakatsuki, Takeru, Osumi, Hiroki, Nakayama, Izuma, Matsushima, Tomohiro, Ichimura, Takashi, Ogura, Mariko, Ozaka, Masato, Suenaga, Mitsukuni, Shinozaki, Eiji, Chin, Keisho, Yamaguchi, Kensei
Publicado 2018

Phase II trial of biweekly cetuximab and irinotecan as third‐line therapy for pretreated KRAS exon 2 wild‐type colorectal cancer

por Osumi, Hiroki, Shinozaki, Eiji, Mashima, Tetsuo, Wakatsuki, Takeru, Suenaga, Mitsukuni, Ichimura, Takashi, Ogura, Mariko, Ota, Yumiko, Nakayama, Izuma, Takahari, Daisuke, Chin, Keisho, Miki, Yoshio, Yamaguchi, Kensei
Publicado 2018

Modified FOLFOX6 as a first-line treatment for patients with advanced gastric cancer with massive ascites or inadequate oral intake

por Osumi, Hiroki, Takahari, Daisuke, Chin, Keisho, Ogura, Mariko, Ichimura, Takashi, Wakatsuki, Takeru, Suzuki, Takeshi, Ota, Yumiko, Nakayama, Izuma, Ooki, Akira, Suenaga, Mitsukuni, Shinozaki, Eiji, Yamaguchi, Kensei
Publicado 2018